{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T16:21:39Z","timestamp":1774887699332,"version":"3.50.1"},"reference-count":28,"publisher":"The Endocrine Society","issue":"8","license":[{"start":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T00:00:00Z","timestamp":1651017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Endocrine Society of Bengal, Kolkata, India","award":["ESB 2018\/11"],"award-info":[{"award-number":["ESB 2018\/11"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>The majority of women with Sheehan syndrome (SS) suffer from sexual dysfunction. Severe androgen deficiency is a major contributory factor. Dehydroepiandrosterone (DHEA) supplementation has been reported to have variable efficacious in improving female sexual dysfunction (FSD) in several trials but studies using DHEA in SS are not available.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We aimed to study the use of DHEA supplementation in patients with SS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this crossover trial, 28 participants with SS (age 39.7\u2005\u00b1\u20058.6 years) were divided into 2 groups (using block randomization) who received DHEA supplements (25 mg twice daily) or matched placebo sequentially for 3 months each. Female Sexual Functioning Index (FSFI) score and serum DHEA sulfate (DHEAS) were measured at baseline and after completion of each phase. Glycemic parameters, lipid profile, and liver enzymes were also measured to assess metabolic side effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There was significant improvement in FSFI score from baseline to end of the study in the DHEA group compared with the placebo group (P\u2005=\u20050.006). Mean FSFI score and most of the individual domains of female sexual dysfunction (FSD) improved with DHEA significantly in both groups (P\u2005=\u20050.001 for each group with DHEA). In those who received DHEA first followed by placebo, FSFI declined significantly after placebo (P\u2005=\u20050.041) but remained at an acceptable level of sexual functioning. Serum DHEAS increased significantly with DHEA treatment. No significant changes in glycemic index, lipid profile, and liver enzymes were noted with DHEA treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A short duration of DHEA supplementation in women with SS with FSD is efficacious and safe.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgac260","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T10:40:27Z","timestamp":1651142427000},"page":"e3395-e3402","source":"Crossref","is-referenced-by-count":9,"title":["DHEA on Sexual Function in Sheehan Syndrome: A Randomized Double-Blind Placebo-Controlled Crossover Trial"],"prefix":"10.1210","volume":"107","author":[{"given":"Soumita","family":"Mandal","sequence":"first","affiliation":[{"name":"Department of Endocrinology, R. G. Kar Medical College , Kolkata , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4580-9589","authenticated-orcid":false,"given":"Pradip","family":"Mukhopadhyay","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Institute of Post Graduate Medical Education & Research , Kolkata , India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5397-961X","authenticated-orcid":false,"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Institute of Post Graduate Medical Education & Research , Kolkata , India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"4","key":"2022071417214418500_CIT0001","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1023\/B:PITU.0000023425.20854.8e","article-title":"Sheehan\u2019s syndrome","volume":"6","author":"Kele\u015ftimur","year":"2003","journal-title":"Pituitary."},{"key":"2022071417214418500_CIT0002","doi-asserted-by":"crossref","first-page":"16092","DOI":"10.1038\/nrdp.2016.92","article-title":"Sheehan syndrome","volume":"2","author":"Karaca","year":"2016","journal-title":"Nat Rev Dis Primers."},{"issue":"12","key":"2022071417214418500_CIT0003","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.eprac.2021.07.013","article-title":"Sexual dysfunction in Sheehan syndrome","volume":"27","author":"Mandal","year":"2021","journal-title":"Endocr Pract."},{"issue":"6","key":"2022071417214418500_CIT0004","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-19-0903","article-title":"Management of endocrine disease: female sexual dysfunction for the endocrinologist","volume":"182","author":"Carosa","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2022071417214418500_CIT0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.mcna.2015.01.011","article-title":"Female sexual dysfunction","volume":"99","author":"Wright","year":"2015","journal-title":"Med Clin North Am"},{"key":"2022071417214418500_CIT0006","doi-asserted-by":"crossref","first-page":"9701384","DOI":"10.1155\/2019\/9701384","article-title":"The potential of hormonal contraception to influence female sexuality","volume":"2019","author":"de Castro Coelho","year":"2019","journal-title":"Int J Reprod Med."},{"key":"2022071417214418500_CIT0007","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1677\/joe.1.06233","article-title":"The endocrinology of sexual arousal","volume":"186","author":"Bancroft","year":"2005","journal-title":"J Endocrinol."},{"key":"2022071417214418500_CIT0008","doi-asserted-by":"crossref","first-page":"S 55","DOI":"10.1016\/S0015-0282(02)02961-8","article-title":"Sexual effects of androgens in women: some theoretical considerations","volume":"77","author":"Bancroft","year":"2002","journal-title":"Fertil Steril."},{"issue":"4","key":"2022071417214418500_CIT0009","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00926230600666261","article-title":"The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population","volume":"32","author":"Ter Kuile","year":"2006","journal-title":"J Sex Marital Ther."},{"issue":"2","key":"2022071417214418500_CIT0010","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/009262300278597","article-title":"The female sexual function index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function","volume":"26","author":"Rosen","year":"2000","journal-title":"J Sex Marital Ther."},{"issue":"1","key":"2022071417214418500_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther."},{"issue":"14","key":"2022071417214418500_CIT0012","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1056\/NEJM199909303411401","article-title":"Dehydroepiandrosterone replacement in women with adrenal insufficiency","volume":"341","author":"Arlt","year":"1999","journal-title":"N Engl J Med."},{"issue":"5","key":"2022071417214418500_CIT0013","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1210\/jcem.87.5.8494","article-title":"Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial","volume":"87","author":"Johannsson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2022071417214418500_CIT0014","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1073\/pnas.97.8.4279","article-title":"Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue","volume":"97","author":"Baulieu","year":"2000","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2022071417214418500_CIT0015","first-page":"1360","article-title":"Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.[Erratum appears in J Clin Endocrinol Metab 1995;80(9);2799.]","volume":"78","author":"Morales","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2022071417214418500_CIT0016","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1210\/jc.2014-2260","article-title":"Androgen therapy in women: a reappraisal: an Endocrine Society clinical practice guideline","volume":"99","author":"Wierman","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2022071417214418500_CIT0017","first-page":"273","article-title":"Androgen replacement therapy in women","volume":"82","author":"Cameron","year":"2004","journal-title":"FertilSteril"},{"key":"2022071417214418500_CIT0018","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/ijem.IJEM_345_20","article-title":"Clinical, endocrine, metabolic profile, and bone health in Sheehan\u2019s syndrome","volume":"24","author":"Mandal","year":"2020","journal-title":"Indian J EndocrMetab."},{"issue":"6","key":"2022071417214418500_CIT0019","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2022071417214418500_CIT0020","first-page":"57","article-title":"Validation of the female sexual function index in Southern India","volume":"26","author":"Varghese","year":"2013","journal-title":"Natl Med J India."},{"issue":"4","key":"2022071417214418500_CIT0021","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/sm2.77","article-title":"The Female Sexual Function Index (FSFI): Translation, Validation, and Cross-Cultural Adaptation of an Urdu Version \u201cFSFI-U\u201d","volume":"3","author":"Rehman","year":"2015","journal-title":"Sex Med."},{"issue":"2","key":"2022071417214418500_CIT0022","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2007-1134","article-title":"Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial","volume":"93","author":"Gurnell","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022071417214418500_CIT0023","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/jc.2002-020769","article-title":"Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month randomized parallel group clinical trial","volume":"88","author":"Lovas","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"12","key":"2022071417214418500_CIT0024","first-page":"4650","article-title":"Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison\u2019s disease in a randomized, double blind trial","volume":"85","author":"Hunt","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2022071417214418500_CIT0025","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1210\/jc.2004-1802","article-title":"Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial","volume":"90","author":"van Thiel","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2022071417214418500_CIT0026","first-page":"3896","article-title":"The effect of dehydroepiandrosterone supplementation to symptomatic perimenopausal women on serum endocrine profiles, lipid parameters, and health-related quality of life","volume":"84","author":"Barnhart","year":"1999","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2022071417214418500_CIT0027","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12020-018-1781-3","article-title":"Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women","volume":"63","author":"Kushnir","year":"2019","journal-title":"Endocrine"},{"issue":"3","key":"2022071417214418500_CIT0028","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.fertnstert.2003.07.035","article-title":"Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men","volume":"81","author":"Acacio","year":"2004","journal-title":"Fertil Steril"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac260\/43691765\/dgac260.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3395\/44886237\/dgac260.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/107\/8\/e3395\/44886237\/dgac260.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T17:23:01Z","timestamp":1657819381000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/107\/8\/e3395\/6575097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,4,27]]},"published-print":{"date-parts":[[2022,7,14]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac260","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,8,1]]},"published":{"date-parts":[[2022,4,27]]}}}